Thyroid receptor activator molecule, TRAM-1, is an androgen receptor coactivator

Citation
Ja. Tan et al., Thyroid receptor activator molecule, TRAM-1, is an androgen receptor coactivator, ENDOCRINOL, 141(9), 2000, pp. 3440-3450
Citations number
94
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
ENDOCRINOLOGY
ISSN journal
00137227 → ACNP
Volume
141
Issue
9
Year of publication
2000
Pages
3440 - 3450
Database
ISI
SICI code
0013-7227(200009)141:9<3440:TRAMTI>2.0.ZU;2-P
Abstract
An androgen receptor (AR) interacting protein was isolated from a HeLa cell complementary DNA library by two-hybrid screening in yeast using the AR DN A and ligand binding domains [amino acids (aa) 481-919] as bait. AR binding of the protein in yeast was dependent on the presence of testosterone or d ihydrotestosterone (DHT). The isolated protein is identical to thyroid rece ptor activator molecule TRAM-1 but lacking aa 1-458. TRAM-1 is a steroid re ceptor coactivator-3 (SRC-3) subtype. In affinity matrix assays, S-35-label ed TRAM-1 bound the GST-AR ligand binding domain (aa 624-919) and GST-AR N- terminal and DNA binding domains (aa 1-660), but not the GST-AR DNA binding domain (aa 544-634) alone. Coexpression of TRAM-1 increased DHT-dependent AR transactivation 5-fold and constitutive activity of AR (aa 1-660) N-term inal and DNA-binding domains increased g-fold. Full-length TRAM-1 (aa 1-142 4) and the partial (aa 459-1424) were AR and GR coactivators as was SRC-1. In human testis, immunostaining of SRC-3 colocalized with AR in nuclei of S ertoli cells and peritubular myoid cells, indicating it could function as a n AR coactivator in these cells. SRC-3 was also present in nuclei of sperma togenic cells where AR was not expressed, suggesting it might also be a coa ctivator with other nuclear receptors that regulate spermatogenesis.